+1 (732) 624-9052
biz@crmedicon.com
Home
About
Company
Core Team
Advisors
Our Advantage
Jobs
Platform
Regulatory Affairs
Medical Affairs
Biopharmaceuticals
Medical Devices
Biometrics
Data Managment
Biostatistics
Statistical Programming.
Bioanalytical Lab Testing
Pharmacovigilance
Training
Solutions
China Strategy
Global Submission
Early Phase
Proof of Concept & Pivotal
Medical Device
Bioequivalence
Resources
News
News & Updates
Events
Q&A
Contact
中文
Uncategorized
Filter by
Categories
Tags
Authors
Show all
All
China Market
CR Medicon Updates
CRO
Events
NMPA
Pharmacovigilance
Q&A
Regulatory
Uncategorized
All
clinical development
clinical trial
medidata
platform
All
Jenny Barkin
Charles Li
Chere Zhou
crmedicon@fanzappy.com
Iain Cai
leew@fanzappy.com
Mudit Verma
Xiaodong Wang
Xingyan Dou
November 19, 2020
November 19, 2020
Categories
Uncategorized
Predicine and CR Medicon form strategic partnership to accelerate global Clinical Trials and Registration Approval
On November 11, 2020, CR Medicon and Predicine jointly announced that it has entered into
[…]
April 6, 2020
April 6, 2020
Categories
Uncategorized
Webinar: China NMPA and US FDA Emergency Approval and Implications to Life Science Companies Relating to COVID-19
Time: Tue, 07 April 2020 11:00 AM – 12:30 PM (EST) As COVID-19 has become
[…]
November 27, 2019
November 27, 2019
Categories
Uncategorized
Regulatory & Registration NEW
November 18, 2019
November 18, 2019
Categories
Uncategorized
CR Medicon Expands Pharmacovigilance Management Capability in China With Oracle Argus
Nanjing, China Nov. 12, 2019 Nanjing CR Medicon Pharmaceutical Technology CO., Ltd., a Gold level member of Oracle
[…]
October 27, 2019
October 27, 2019
Categories
Uncategorized
CR Medicon Participated in 10th China International Medical Device Regulatory Forum (CIMDR)
On September 25-27, 2019, the China Food and Drug International Exchange Center held the 10th
[…]
September 17, 2019
September 17, 2019
Categories
Uncategorized
Regulatory Affairs
中文